Announcements

Accenture plc Chair and CEO Julie Spellman Sweet filed a Form 4 on November 9, 2026, disclosing a purchase of 144 Class A ordinary shares on November 5, 2026, through the company's Voluntary Equity Investment Program.

John F. Walsh, CEO-Americas of Accenture plc, filed a Form 4 on November 9, 2026, disclosing a purchase of 103 Class A ordinary shares on November 5, 2026, through the Accenture Voluntary Equity Investment Program.

Accenture plc Chief Leadership and HR Officer Katherine Lee Clifford filed a Form 4 on November 9, 2026, disclosing a purchase of 65 Class A ordinary shares on November 5, 2026, through the company's Voluntary Equity Investment Program.

A Form 4 filed on November 9, 2026, discloses that Joel Unruch, General Counsel, Corporate Secretary, and Chief Risk Officer of Accenture plc (NYSE:ACN), acquired 102 Class A ordinary shares on November 5, 2026, through the company's Voluntary Equity Investment Program.

ADAR1 Capital Management, LLC filed a Form 4 on November 9, 2026, disclosing two open-market purchases of NextCure, Inc. common stock totaling 4,686 shares made on November 5 and November 6, 2026.

Manish Sharma, Strategy/Reinvention Services Officer at Accenture plc (NYSE:ACN), filed a Form 4 on November 9, 2026, disclosing the acquisition of 68 Class A ordinary shares on November 5, 2026.

Director Michelle J. Goldberg filed a Form 4 with the SEC on November 9, 2026, disclosing a purchase of 25,000 shares of Lumen Technologies, Inc. common stock on November 6, 2026.